Effects of nanoliposomal irinotecan (nal-IRI;MM-398) 5-Fluorouracil and leucavorin (5-FU/LV) on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-based therapy.
Von Hoff, D
de Jong, F
Hubner, Richard A
AffiliationWest German Cancer Centre, University Hospital Essen, Essen, Germany